Rochelle Hines In The News

Profile: Rochelle Hines
Researchers at UNLV study psychedelic drugs for use in mental health
K.N.P.R. News
Psychedelic drugs such as psilocybin, LSD and mescaline are illegal in most of the country, considered Class 1 drugs by the federal government.
‘New Hope’ for Sleep Disorders Tied to Down Syndrome, Autism, & Other Intellectual Disabilities
Sleep Review
Science is one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.
Science is getting closer to reduce seizures in intellectually disabled: Study
The Print
Science is getting one step closer to developing drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.
Science is getting closer to reduce seizures in intellectually disabled: Study
Ani
Science is getting one step closer to developing drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.
Science one step closer to turning off seizures, sleep disturbances linked to intellectual disability
Science Daily
Science is one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.
Scientists one step closer to 'turning off' epileptic seizures – 'new hope' for thousands
Express UK
Thousands suffering from epilepsy have been given new hope as a new breakthrough brings scientists one step closer to being able to "turn off" epileptic seizures.
Science a step forward to "turn off" epileptic seizures, sleep disorders related to intellectual disability
Barletta Web
Science is a step towards developing targeted drug therapies that can reduce seizures, sleep disturbances and related symptoms common in people with intellectual disabilities.
Gene Findings Could Lead to Sleep Treatment for People With Intellectual Disability
Technology Networks
Science is one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.